• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 管理:现状与未来展望。

Management of COVID-19: current status and future prospects.

机构信息

Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA; Asghar-Lab, Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Boca Raton, FL 33431, USA.

Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford School of Medicine, Palo Alto, CA 94304, USA.

出版信息

Microbes Infect. 2021 May-Jun;23(4-5):104832. doi: 10.1016/j.micinf.2021.104832. Epub 2021 Apr 17.

DOI:10.1016/j.micinf.2021.104832
PMID:33872807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052512/
Abstract

COVID-19, a highly transmissible pandemic disease, is affecting millions of lives around the world. Severely infected patients show acute respiratory distress symptoms. Sustainable management strategies are required to save lives of the infected people and further preventing spread of the virus. Diagnosis, treatment, and vaccination development initiatives are already exhibited from the scientific community to fight against this virus. In this review, we primarily discuss the management strategies including prevention of spread, prophylaxis, vaccinations, and treatment for COVID-19. Further, analysis of vaccine development status and performance are also briefly discussed. Global socioeconomic impact of COVID-19 is also analyzed as part of this review.

摘要

COVID-19,一种高度传染性的大流行病,正在影响着全球数百万人的生命。严重感染的患者表现出急性呼吸窘迫症状。需要可持续的管理策略来拯救感染者的生命,并进一步防止病毒的传播。科学界已经提出了诊断、治疗和疫苗开发的举措来对抗这种病毒。在这篇综述中,我们主要讨论了包括 COVID-19 的传播预防、预防措施、疫苗接种和治疗在内的管理策略。此外,还简要讨论了疫苗开发状况和性能的分析。COVID-19 对全球社会经济的影响也作为本综述的一部分进行了分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/b20643a0f1bf/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/97f61ae4f761/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/36700e072bb2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/2323cdcda57c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/bf8df5d38f0f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/b20643a0f1bf/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/97f61ae4f761/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/36700e072bb2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/2323cdcda57c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/bf8df5d38f0f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb4/8052512/b20643a0f1bf/gr5_lrg.jpg

相似文献

1
Management of COVID-19: current status and future prospects.COVID-19 管理:现状与未来展望。
Microbes Infect. 2021 May-Jun;23(4-5):104832. doi: 10.1016/j.micinf.2021.104832. Epub 2021 Apr 17.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.新型冠状病毒的治疗措施:现状与未来展望综述。
Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230.
4
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence.COVID-19 的流行病学、发病机制、临床特征、诊断和治疗:当前证据的综述。
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621. doi: 10.1080/17512433.2021.1902303. Epub 2021 May 3.
5
Rapid evolution of the COVID-19 pandemic calls for a unified public health response.新冠疫情的快速演变需要采取统一的公共卫生应对措施。
Biosci Trends. 2021 Sep 22;15(4):196-200. doi: 10.5582/bst.2021.01261. Epub 2021 Jul 1.
6
COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.新型冠状病毒肺炎(COVID-19):SARS-CoV-2 的形态与机制、全球疫情爆发、药物治疗、疫苗及病毒的未来。
Front Biosci (Elite Ed). 2021 Dec 20;13(2):272-290. doi: 10.52586/E884.
7
[Covid-19, september 2020: fall storm warning].[2020年9月,新冠疫情:秋季风暴预警]
Virologie (Montrouge). 2020 Dec 1;24(6):361-367. doi: 10.1684/vir.2020.0865.
8
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.治疗方法和疫苗方面的最新进展,以应对 COVID-19/SARS-CoV-2。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3034-3042. doi: 10.1080/21645515.2020.1794685. Epub 2020 Aug 26.
9
SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.SARS-CoV-2:基因组学、风险评估、潜在治疗方法和疫苗开发的最新进展。
Int J Environ Res Public Health. 2021 Feb 8;18(4):1626. doi: 10.3390/ijerph18041626.
10
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.疫苗接种对预防 COVID-19 的潜在影响:基本原理、临床证据、风险和公共卫生考虑。
Expert Rev Vaccines. 2020 Oct;19(10):919-936. doi: 10.1080/14760584.2020.1825951. Epub 2020 Oct 6.

引用本文的文献

1
Can Labs Help With Vaccination? In Vitro Tests in Diagnosis of Allergy to COVID-19 Vaccines-A Systematic Review.实验室能否助力疫苗接种?新冠疫苗过敏诊断中的体外检测——一项系统评价。
Immun Inflamm Dis. 2025 May;13(5):e70206. doi: 10.1002/iid3.70206.
2
Development of a Diagnostic Microfluidic Chip for SARS-CoV-2 Detection in Saliva and Nasopharyngeal Samples.用于唾液和鼻咽样本中 SARS-CoV-2 检测的诊断微流控芯片的研制。
Viruses. 2024 Jul 25;16(8):1190. doi: 10.3390/v16081190.
3
Predictors for cause-specific and timing of deaths in patients with COVID-19: a cohort study in Taiwan.

本文引用的文献

1
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和抗体:当前的认识、挑战与展望
Antib Ther. 2020 Dec 28;3(4):285-299. doi: 10.1093/abt/tbaa028. eCollection 2020 Dec.
2
Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic.全球大流行期间新兴的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基于抗体的疗法。
Antib Ther. 2020 Nov 24;3(4):246-256. doi: 10.1093/abt/tbaa025. eCollection 2020 Dec.
3
Development of a Point-of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads.
预测 COVID-19 患者的死因和死亡时间的因素:台湾的一项队列研究。
BMC Infect Dis. 2024 Aug 20;24(1):840. doi: 10.1186/s12879-024-09654-w.
4
Serum Adiponectin Predicts COVID-19 Severity.血清脂联素可预测新冠病毒疾病的严重程度。
Biomedicines. 2024 May 9;12(5):1043. doi: 10.3390/biomedicines12051043.
5
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.COVID-19 的潜在治疗方法:药物再利用和治疗干预。
J Pharmacol Sci. 2023 May;152(1):1-21. doi: 10.1016/j.jphs.2023.02.004. Epub 2023 Feb 15.
6
Development of a wearable belt with integrated sensors for measuring multiple physiological parameters related to heart failure.研发一种带有集成传感器的可穿戴腰带,用于测量与心力衰竭相关的多个生理参数。
Sci Rep. 2022 Nov 24;12(1):20264. doi: 10.1038/s41598-022-23680-1.
7
Occurrence and risk assessment of typical PPCPs and biodegradation pathway of ribavirin in wastewater treatment plants.污水处理厂中典型持久性有机污染物的存在情况及风险评估与利巴韦林的生物降解途径
Environ Sci Ecotechnol. 2022 May 3;11:100184. doi: 10.1016/j.ese.2022.100184. eCollection 2022 Jul.
8
Review on Approved and Inprogress COVID-19 Vaccines.已批准和正在研发的新冠疫苗综述。
Iran J Pharm Res. 2022 Jan 24;21(1):e124228. doi: 10.5812/ijpr.124228. eCollection 2022 Dec.
9
Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.SARS-CoV-19 疫苗预防的最新进展。
Int Immunopharmacol. 2022 Oct;111:109175. doi: 10.1016/j.intimp.2022.109175. Epub 2022 Aug 17.
10
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir.治疗 SARS-CoV-2 感染的困境:法匹拉韦与瑞德西韦。
Biomed Pharmacother. 2022 Mar;147:112700. doi: 10.1016/j.biopha.2022.112700. Epub 2022 Feb 4.
基于高折射率抗体包被微球的 HIV-1 病毒载量即时检测方法的建立。
Sensors (Basel). 2021 Mar 5;21(5):1819. doi: 10.3390/s21051819.
4
Latest results put Oxford-AstraZeneca COVID vaccine back on track.最新结果使牛津-阿斯利康新冠疫苗重回正轨。
Nature. 2021 Mar 25. doi: 10.1038/d41586-021-00836-z.
5
What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.科学家们对牛津大学-阿斯利康新冠疫苗了解和不了解的情况。
Nature. 2021 Apr;592(7852):15-17. doi: 10.1038/d41586-021-00785-7.
6
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.美国免疫实践咨询委员会关于使用杨森新冠疫苗的临时建议 - 2021年2月
MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):329-332. doi: 10.15585/mmwr.mm7009e4.
7
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
8
Diagnosis for COVID-19: current status and future prospects.新型冠状病毒肺炎的诊断:现状与展望。
Expert Rev Mol Diagn. 2021 Mar;21(3):269-288. doi: 10.1080/14737159.2021.1894930. Epub 2021 Mar 7.
9
Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.潜在的COVID-19药物(卡莫司他和那法莫司他)与人丝氨酸蛋白酶TMPRSS2的自发结合。
Comput Struct Biotechnol J. 2020 Dec 28;19:467-476. doi: 10.1016/j.csbj.2020.12.035. eCollection 2021.
10
COVID-19 vaccines: where we stand and challenges ahead.COVID-19 疫苗:我们的现状和未来的挑战。
Cell Death Differ. 2021 Feb;28(2):626-639. doi: 10.1038/s41418-020-00720-9. Epub 2021 Jan 21.